Skip to content

Comparison of quality anesthesia of two anesthetic drugs in direct laryngoscopy.

Comparison of Dexmedetomidine and Remifentanil in the Anesthesia for Direct Laryngoscopy: A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20121204011662N13
Enrollment
60
Registered
2020-02-17
Start date
2020-01-20
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Survey of anesthesia for direct laryngoscopy..

Interventions

Intervention 1: Intervention group 1: After induction of anesthesia,patients in group Awill be received an IV infusion of dexmedetomidine 1 mcg/Kg over five minutes with a 20 ml syringe with the label

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: All patients who will candidate for direct laparoscopy under general anesthesia will be enrolled.

Exclusion criteria

Exclusion criteria: Patients with history of ischemic heart disease Patients with history of heart failure Patients with history of asthma Patients with history of renal failure Patients with history of hepatic failure Patients who are morbidly obese Patients in emergency situation

Design outcomes

Primary

MeasureTime frame
Mean arterial blood pressure (MAP). Timepoint: Values will record at baseline, 5, 10, 15, 30, and 45, minutes. Method of measurement: Non invasive blood pressure monitoring.;Heart rate per minute. Timepoint: Values will record at baseline, 5, 10, 15, 30, and 45, minutes. Method of measurement: Electrocardiogram.

Secondary

MeasureTime frame
Sedation Score. Timepoint: Every 15 minutes in recovery room. Method of measurement: Ramsay Scale.;Attacks of respiratory depression. Timepoint: Every 15 minutes in recovery room. Method of measurement: Defined as a respiratory rate < 8 breaths/min.;Incidence of nausea and vomiting. Timepoint: Every 15 minutes in recovery room. Method of measurement: 0: No nausea and vomiting, 1: Nuasea without Vomiting, 2: Both Nausea and Vomiting.;Severity of postoperative pain. Timepoint: Every 15 minutes in recovery room. Method of measurement: Visual analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadAli Sahmeddini

Shiraz University of Medical Sciences

sahmeddin@sums.ac.ir+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026